Psyence Biomedical PBM
NASDAQ PBM
$4.33 +0.40 (+10.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Psyence Biomedical Ltd. (PBM) Preferred Stock Liabilities (2023)

Psyence Biomedical (PBM) posted quarterly Preferred Stock Liabilities of $12571.9 billion for Q3 2023.

Psyence Biomedical Ltd. (PBM) Preferred Stock Liabilities (2023) Analysis & Trends

Psyence Biomedical's Preferred Stock Liabilities history runs 1 years deep, the most recent figure standing at $12571.9 billion for Q3 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2023 12,571.86 Bn